{"id":8914,"date":"2021-03-08T13:44:12","date_gmt":"2021-03-08T13:44:12","guid":{"rendered":"https:\/\/cfi.co\/awards\/?p=8914"},"modified":"2021-03-08T13:44:12","modified_gmt":"2021-03-08T13:44:12","slug":"cessatech-a-s-best-medical-treatment-ipo-nordics-2020","status":"publish","type":"post","link":"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/","title":{"rendered":"Cessatech A\/S: Best Medical Treatment IPO Nordics 2020"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-8915\" src=\"https:\/\/cfi.co\/awards\/wp-content\/uploads\/2021\/03\/Cessatech.jpg\" alt=\"Cessatech\" width=\"324\" height=\"116\" srcset=\"https:\/\/cfi.co\/awards\/wp-content\/uploads\/2021\/03\/Cessatech.jpg 324w, https:\/\/cfi.co\/awards\/wp-content\/uploads\/2021\/03\/Cessatech-300x107.jpg 300w\" sizes=\"auto, (max-width: 324px) 100vw, 324px\" \/><\/p>\n<p style=\"text-align: justify;\">Cessatech credits the substantial oversubscription of its recent IPO to a high-calibre team with strong skills and a collaborative work ethic. The Danish pharmaceuticals company invites investors to reimagine healthcare in the context of evidence-based treatment specially designed for children. Cessatech starts with drugs that have already proven effective in adults, but have yet to be adapted to address children\u2019s unmet medical needs. It fast-tracks clinical trials \u2014 without compromising on strict standards of quality and safety \u2014 to develop innovative solutions with a reduced risk profile and a shorter time to market. The company\u2019s leadership team brings a diverse range of experiences to the table, from drug development and paediatric analgesic research to product launches and capital raising. The pipeline product (CT001) is an analgesic non-invasive nasal spray for children experiencing acute pain, including that caused by medical procedures. Cessatech based the development of the drug on a decade\u2019s worth of clinical experience. The treatment has shown promising preliminary results in a collaborative five-year retrospective study and was proven safe and effective through a clinical Phase II trial at Copenhagen University Hospital (Rigshospitalet), which is where Cessatech began as an offshoot project. Cessatech will begin late-stage development of the drug this year. Other products in the pipeline include a solution for MRI sedation and a local anaesthetic gel. The CFI.co judging panel is pleased to announce Cessatech as the winner of the 2020 award for Best Medical Treatment IPO (Nordics).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cessatech credits the substantial oversubscription of its recent IPO to a high-calibre team with strong skills and a collaborative work ethic. The Danish pharmaceuticals company invites investors to reimagine healthcare<\/p>\n","protected":false},"author":1,"featured_media":8916,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[5,53,14],"tags":[63],"class_list":["post-8914","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-europe","category-front","category-industries","tag-ipo"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.6 (Yoast SEO v27.0) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Cessatech A\/S: Best Medical Treatment IPO Nordics 2020 - CFI.co<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cessatech A\/S: Best Medical Treatment IPO Nordics 2020\" \/>\n<meta property=\"og:description\" content=\"Cessatech credits the substantial oversubscription of its recent IPO to a high-calibre team with strong skills and a collaborative work ethic. The Danish pharmaceuticals company invites investors to reimagine healthcare\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"CFI.co\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CapitalFinanceInternational\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-08T13:44:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cfi.co\/awards\/wp-content\/uploads\/2021\/03\/Cessatech-thumb.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"349\" \/>\n\t<meta property=\"og:image:height\" content=\"218\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"marten\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@CFIMagazine\" \/>\n<meta name=\"twitter:site\" content=\"@CFIMagazine\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"marten\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/\"},\"author\":{\"name\":\"marten\",\"@id\":\"https:\/\/cfi.co\/awards\/#\/schema\/person\/e3ad9b01223c3a8168d49fc9b884a909\"},\"headline\":\"Cessatech A\/S: Best Medical Treatment IPO Nordics 2020\",\"datePublished\":\"2021-03-08T13:44:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/\"},\"wordCount\":250,\"image\":{\"@id\":\"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cfi.co\/awards\/wp-content\/uploads\/2021\/03\/Cessatech-thumb.jpg\",\"keywords\":[\"IPO\"],\"articleSection\":[\"Europe\",\"FRONT\",\"Industries\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/\",\"url\":\"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/\",\"name\":\"Cessatech A\/S: Best Medical Treatment IPO Nordics 2020 - CFI.co\",\"isPartOf\":{\"@id\":\"https:\/\/cfi.co\/awards\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cfi.co\/awards\/wp-content\/uploads\/2021\/03\/Cessatech-thumb.jpg\",\"datePublished\":\"2021-03-08T13:44:12+00:00\",\"author\":{\"@id\":\"https:\/\/cfi.co\/awards\/#\/schema\/person\/e3ad9b01223c3a8168d49fc9b884a909\"},\"breadcrumb\":{\"@id\":\"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/#primaryimage\",\"url\":\"https:\/\/cfi.co\/awards\/wp-content\/uploads\/2021\/03\/Cessatech-thumb.jpg\",\"contentUrl\":\"https:\/\/cfi.co\/awards\/wp-content\/uploads\/2021\/03\/Cessatech-thumb.jpg\",\"width\":349,\"height\":218,\"caption\":\"Cessatech-thumb\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cfi.co\/awards\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cessatech A\/S: Best Medical Treatment IPO Nordics 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cfi.co\/awards\/#website\",\"url\":\"https:\/\/cfi.co\/awards\/\",\"name\":\"CFI.co\",\"description\":\"Awards\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cfi.co\/awards\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cfi.co\/awards\/#\/schema\/person\/e3ad9b01223c3a8168d49fc9b884a909\",\"name\":\"marten\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cfi.co\/awards\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/cba215529388907795149c7f3a29e812b17a839430ad09073ac8adeb2fd3b7f4?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/cba215529388907795149c7f3a29e812b17a839430ad09073ac8adeb2fd3b7f4?s=96&d=blank&r=g\",\"caption\":\"marten\"},\"url\":\"https:\/\/cfi.co\/awards\/author\/marten\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Cessatech A\/S: Best Medical Treatment IPO Nordics 2020 - CFI.co","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/","og_locale":"en_US","og_type":"article","og_title":"Cessatech A\/S: Best Medical Treatment IPO Nordics 2020","og_description":"Cessatech credits the substantial oversubscription of its recent IPO to a high-calibre team with strong skills and a collaborative work ethic. The Danish pharmaceuticals company invites investors to reimagine healthcare","og_url":"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/","og_site_name":"CFI.co","article_publisher":"https:\/\/www.facebook.com\/CapitalFinanceInternational\/","article_published_time":"2021-03-08T13:44:12+00:00","og_image":[{"width":349,"height":218,"url":"https:\/\/cfi.co\/awards\/wp-content\/uploads\/2021\/03\/Cessatech-thumb.jpg","type":"image\/jpeg"}],"author":"marten","twitter_card":"summary_large_image","twitter_creator":"@CFIMagazine","twitter_site":"@CFIMagazine","twitter_misc":{"Written by":"marten","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/#article","isPartOf":{"@id":"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/"},"author":{"name":"marten","@id":"https:\/\/cfi.co\/awards\/#\/schema\/person\/e3ad9b01223c3a8168d49fc9b884a909"},"headline":"Cessatech A\/S: Best Medical Treatment IPO Nordics 2020","datePublished":"2021-03-08T13:44:12+00:00","mainEntityOfPage":{"@id":"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/"},"wordCount":250,"image":{"@id":"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/cfi.co\/awards\/wp-content\/uploads\/2021\/03\/Cessatech-thumb.jpg","keywords":["IPO"],"articleSection":["Europe","FRONT","Industries"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/","url":"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/","name":"Cessatech A\/S: Best Medical Treatment IPO Nordics 2020 - CFI.co","isPartOf":{"@id":"https:\/\/cfi.co\/awards\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/#primaryimage"},"image":{"@id":"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/cfi.co\/awards\/wp-content\/uploads\/2021\/03\/Cessatech-thumb.jpg","datePublished":"2021-03-08T13:44:12+00:00","author":{"@id":"https:\/\/cfi.co\/awards\/#\/schema\/person\/e3ad9b01223c3a8168d49fc9b884a909"},"breadcrumb":{"@id":"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/#primaryimage","url":"https:\/\/cfi.co\/awards\/wp-content\/uploads\/2021\/03\/Cessatech-thumb.jpg","contentUrl":"https:\/\/cfi.co\/awards\/wp-content\/uploads\/2021\/03\/Cessatech-thumb.jpg","width":349,"height":218,"caption":"Cessatech-thumb"},{"@type":"BreadcrumbList","@id":"https:\/\/cfi.co\/awards\/europe\/2021\/cessatech-a-s-best-medical-treatment-ipo-nordics-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cfi.co\/awards\/"},{"@type":"ListItem","position":2,"name":"Cessatech A\/S: Best Medical Treatment IPO Nordics 2020"}]},{"@type":"WebSite","@id":"https:\/\/cfi.co\/awards\/#website","url":"https:\/\/cfi.co\/awards\/","name":"CFI.co","description":"Awards","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cfi.co\/awards\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cfi.co\/awards\/#\/schema\/person\/e3ad9b01223c3a8168d49fc9b884a909","name":"marten","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cfi.co\/awards\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/cba215529388907795149c7f3a29e812b17a839430ad09073ac8adeb2fd3b7f4?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/cba215529388907795149c7f3a29e812b17a839430ad09073ac8adeb2fd3b7f4?s=96&d=blank&r=g","caption":"marten"},"url":"https:\/\/cfi.co\/awards\/author\/marten\/"}]}},"_links":{"self":[{"href":"https:\/\/cfi.co\/awards\/wp-json\/wp\/v2\/posts\/8914","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cfi.co\/awards\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cfi.co\/awards\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cfi.co\/awards\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cfi.co\/awards\/wp-json\/wp\/v2\/comments?post=8914"}],"version-history":[{"count":0,"href":"https:\/\/cfi.co\/awards\/wp-json\/wp\/v2\/posts\/8914\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cfi.co\/awards\/wp-json\/wp\/v2\/media\/8916"}],"wp:attachment":[{"href":"https:\/\/cfi.co\/awards\/wp-json\/wp\/v2\/media?parent=8914"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cfi.co\/awards\/wp-json\/wp\/v2\/categories?post=8914"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cfi.co\/awards\/wp-json\/wp\/v2\/tags?post=8914"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}